JP2566960B2 - Method for producing (R) -r-substituted-β-hydroxybutyric acid ester - Google Patents
Method for producing (R) -r-substituted-β-hydroxybutyric acid esterInfo
- Publication number
- JP2566960B2 JP2566960B2 JP62142916A JP14291687A JP2566960B2 JP 2566960 B2 JP2566960 B2 JP 2566960B2 JP 62142916 A JP62142916 A JP 62142916A JP 14291687 A JP14291687 A JP 14291687A JP 2566960 B2 JP2566960 B2 JP 2566960B2
- Authority
- JP
- Japan
- Prior art keywords
- substituted
- acid ester
- hydroxybutyric acid
- producing
- enzyme
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- -1 (R) -r-substituted-β-hydroxybutyric acid ester Chemical class 0.000 title claims description 17
- 238000004519 manufacturing process Methods 0.000 title description 5
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 claims description 4
- 238000000034 method Methods 0.000 claims description 4
- 229930024421 Adenine Natural products 0.000 claims description 2
- GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 claims description 2
- 229910019142 PO4 Inorganic materials 0.000 claims description 2
- 229960000643 adenine Drugs 0.000 claims description 2
- 230000001419 dependent effect Effects 0.000 claims description 2
- 229960003966 nicotinamide Drugs 0.000 claims description 2
- 235000005152 nicotinamide Nutrition 0.000 claims description 2
- 239000011570 nicotinamide Substances 0.000 claims description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims description 2
- 239000010452 phosphate Substances 0.000 claims description 2
- 102000004190 Enzymes Human genes 0.000 description 17
- 108090000790 Enzymes Proteins 0.000 description 17
- 230000000694 effects Effects 0.000 description 13
- BAWFJGJZGIEFAR-NNYOXOHSSA-N NAD zwitterion Chemical compound NC(=O)C1=CC=C[N+]([C@H]2[C@@H]([C@H](O)[C@@H](COP([O-])(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 BAWFJGJZGIEFAR-NNYOXOHSSA-N 0.000 description 12
- 229950006238 nadide Drugs 0.000 description 12
- 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 description 10
- 238000006243 chemical reaction Methods 0.000 description 9
- 239000000047 product Substances 0.000 description 7
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- 238000005481 NMR spectroscopy Methods 0.000 description 6
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 6
- 230000003287 optical effect Effects 0.000 description 6
- 239000000758 substrate Substances 0.000 description 6
- 102000004316 Oxidoreductases Human genes 0.000 description 5
- 108090000854 Oxidoreductases Proteins 0.000 description 5
- 238000005119 centrifugation Methods 0.000 description 5
- 238000001641 gel filtration chromatography Methods 0.000 description 4
- 239000008363 phosphate buffer Substances 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 229920005654 Sephadex Polymers 0.000 description 3
- 239000012507 Sephadex™ Substances 0.000 description 3
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 3
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 3
- 235000011130 ammonium sulphate Nutrition 0.000 description 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 3
- 239000000872 buffer Substances 0.000 description 3
- 239000005515 coenzyme Substances 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 238000004128 high performance liquid chromatography Methods 0.000 description 3
- 150000002576 ketones Chemical class 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 239000001301 oxygen Substances 0.000 description 3
- 229910052760 oxygen Inorganic materials 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- ASNHGEVAWNWCRQ-UHFFFAOYSA-N 4-(hydroxymethyl)oxolane-2,3,4-triol Chemical compound OCC1(O)COC(O)C1O ASNHGEVAWNWCRQ-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 101000841267 Homo sapiens Long chain 3-hydroxyacyl-CoA dehydrogenase Proteins 0.000 description 2
- 102100029107 Long chain 3-hydroxyacyl-CoA dehydrogenase Human genes 0.000 description 2
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 2
- 240000008042 Zea mays Species 0.000 description 2
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 2
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 2
- 238000002835 absorbance Methods 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 235000005822 corn Nutrition 0.000 description 2
- 238000012258 culturing Methods 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000010828 elution Methods 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- OHLRLMWUFVDREV-UHFFFAOYSA-N ethyl 4-chloro-3-oxobutanoate Chemical compound CCOC(=O)CC(=O)CCl OHLRLMWUFVDREV-UHFFFAOYSA-N 0.000 description 2
- 238000002523 gelfiltration Methods 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 230000000704 physical effect Effects 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 238000006722 reduction reaction Methods 0.000 description 2
- 238000011218 seed culture Methods 0.000 description 2
- HEMHJVSKTPXQMS-UHFFFAOYSA-M sodium hydroxide Inorganic materials [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 2
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- JJYKJUXBWFATTE-SECBINFHSA-N (2r)-3,3,3-trifluoro-2-methoxy-2-phenylpropanoic acid Chemical compound CO[C@](C(O)=O)(C(F)(F)F)C1=CC=CC=C1 JJYKJUXBWFATTE-SECBINFHSA-N 0.000 description 1
- NGQQUXXTDZADNX-UHFFFAOYSA-N 2,3,4,5-tetrachlorofuran Chemical compound ClC=1OC(Cl)=C(Cl)C=1Cl NGQQUXXTDZADNX-UHFFFAOYSA-N 0.000 description 1
- GGZZISOUXJHYOY-UHFFFAOYSA-N 8-amino-4-hydroxynaphthalene-2-sulfonic acid Chemical compound C1=C(S(O)(=O)=O)C=C2C(N)=CC=CC2=C1O GGZZISOUXJHYOY-UHFFFAOYSA-N 0.000 description 1
- 102000007698 Alcohol dehydrogenase Human genes 0.000 description 1
- 108010021809 Alcohol dehydrogenase Proteins 0.000 description 1
- 108010053754 Aldehyde reductase Proteins 0.000 description 1
- 102100027265 Aldo-keto reductase family 1 member B1 Human genes 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 1
- 101710088194 Dehydrogenase Proteins 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- RGHNJXZEOKUKBD-SQOUGZDYSA-N Gluconic acid Natural products OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 1
- 108010050375 Glucose 1-Dehydrogenase Proteins 0.000 description 1
- XJLXINKUBYWONI-NNYOXOHSSA-O NADP(+) Chemical compound NC(=O)C1=CC=C[N+]([C@H]2[C@@H]([C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](OP(O)(O)=O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 XJLXINKUBYWONI-NNYOXOHSSA-O 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 241000228393 Sporidiobolus salmonicolor Species 0.000 description 1
- 241000186339 Thermoanaerobacter Species 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 238000001042 affinity chromatography Methods 0.000 description 1
- 239000003905 agrochemical Substances 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 239000001166 ammonium sulphate Substances 0.000 description 1
- 125000000852 azido group Chemical group *N=[N+]=[N-] 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 125000002603 chloroethyl group Chemical group [H]C([*])([H])C([H])([H])Cl 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 125000004185 ester group Chemical group 0.000 description 1
- ZAJNMXDBJKCCAT-UHFFFAOYSA-N ethyl 4-chloro-3-hydroxybutanoate Chemical compound CCOC(=O)CC(O)CCl ZAJNMXDBJKCCAT-UHFFFAOYSA-N 0.000 description 1
- XYIBRDXRRQCHLP-UHFFFAOYSA-N ethyl acetoacetate Chemical class CCOC(=O)CC(C)=O XYIBRDXRRQCHLP-UHFFFAOYSA-N 0.000 description 1
- 125000001153 fluoro group Chemical group F* 0.000 description 1
- 238000005194 fractionation Methods 0.000 description 1
- 238000004817 gas chromatography Methods 0.000 description 1
- 239000000174 gluconic acid Substances 0.000 description 1
- 235000012208 gluconic acid Nutrition 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000004255 ion exchange chromatography Methods 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000011785 micronutrient Substances 0.000 description 1
- 235000013369 micronutrients Nutrition 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- JJYKJUXBWFATTE-UHFFFAOYSA-N mosher's acid Chemical compound COC(C(O)=O)(C(F)(F)F)C1=CC=CC=C1 JJYKJUXBWFATTE-UHFFFAOYSA-N 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 238000000108 ultra-filtration Methods 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/52—Improvements relating to the production of bulk chemicals using catalysts, e.g. selective catalysts
Landscapes
- Enzymes And Modification Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Description
【発明の詳細な説明】 〔産業上の利用分野〕 近年、光学活性オキシ酸誘導体類は、医薬、農薬合成
中間体として、その有用性が増しつつある。DETAILED DESCRIPTION OF THE INVENTION [Industrial Application Field] In recent years, the usefulness of optically active oxyacid derivatives has been increasing as a synthetic intermediate for medicines and agricultural chemicals.
これら光学活性オキシ酸誘導体類の内、(R)−γ−
置換−β−ハイドロキシ酪酸エステルの製造法につき種
々検討した結果、本発明者らにより見出された新規還元
酵素を用いれば効果的にγ−置換アセト酢酸エステルか
ら製造出来ることを見出し本発明を完成した。Among these optically active oxyacid derivatives, (R) -γ-
As a result of various studies on a method for producing a substituted -β-hydroxybutyric acid ester, it was found that a novel reductase found by the present inventors can be used to effectively produce a γ-substituted acetoacetic acid ester, thereby completing the present invention. did.
従来より、γ−置換アセト酢酸エステルに作用し、
(R)−γ−置換−β−ハイドロキシ酵素エステルを生
成するには、微生物起源としては酵母由来のL−β−ハ
イドロキシアシルCoAデヒドロゲナーゼ〔EC1、1、1、
35〕(特開昭59−118093号公報)及びサーモアネアロビ
ウムブロキイ(Thermoanaerobium brckii)由来のアル
コールデヒドロゲナーゼ〔EC1.1.1.2〕(J.A.C.S.、198
5、107、4028)が知られている。Conventionally, acting on γ-substituted acetoacetic ester,
To produce a (R) -γ-substituted-β-hydroxy enzyme ester, yeast-derived L-β-hydroxyacyl CoA dehydrogenase [EC1, 1, 1,
35] (JP-A-59-118093) and alcohol dehydrogenase derived from Thermoanaerobium brckii [EC1.1.1.2] (JACS, 198).
5, 107 , 4028) are known.
しかしながら、前者は反応性・温度安定性の点で、又
後者は嫌気培養である等改善の余地があり、これらを使
用した(R)−γ−置換−β−ハイドロキシ酪酸エステ
ルの製造法は実用的とは言い難かつた。However, the former has room for improvement in terms of reactivity and temperature stability, and the latter is anaerobic culture. Therefore, a method for producing (R) -γ-substituted-β-hydroxybutyric acid ester using these is practical. It was hard to call it a target.
〔問題点を解決するための手段〕 本発明は、γ−置換アセト酢酸エステルにスポロボロ
マイセス属由来の還元型ニコチンアミド・アデニン・ジ
ヌクレオチド・リン酸(以下NADPHと言う)依存性還元
酵素を作用させる事を特徴とする(R)−γ−置換−β
−ハイドロキシ酪酸エステルの製造法である。[Means for Solving Problems] The present invention relates to a reduced nicotinamide / adenine / dinucleotide / phosphate (hereinafter referred to as NADPH) -dependent reductase derived from Sporoboromyces sp. (R) -γ-substitution-β characterized in that
A method for producing hydroxybutyric acid ester.
本発明で使用する上記還元酵素は、スポロボロマイセ
ス・サルモニカラー(SPorobolomyces salmonicolor)I
FO1038から還元能力を有する酵素を抽出製精製したもの
である。この酵素は公知酵素に比し、実用上優れた諸物
性を有する新規還元酵素であることが明らかなので別途
提案した。The above-mentioned reductase used in the present invention is Sporobolomyces salmonicolor I
An enzyme having reducing ability was extracted and purified from FO1038. This enzyme was newly proposed because it is clear that it is a novel reductase having various physical properties that are practically superior to known enzymes.
次に、本発明で使用する酵素の調整とその諸物性につ
き具体的に記す。Next, the preparation of the enzyme used in the present invention and its various physical properties will be specifically described.
グルコース5%、コーンステイープリカー5%からな
る培地(pH5.0)で生育せしめたスポロボロモマイセス
サルモニカラーIFO1038を、遠心分離により集菌し、
リン酸緩衝液で洗浄後、ダイノミル(シンマルエンター
プライズ社製)で細胞を破砕し、酵素を抽出する。遠心
分離後、得られた無細胞抽出液を硫安分画し、60〜80
%、飽和画分を集める。1晩透析後、DEAE−セフアセル
(フアーマシア社製)カラムに吸着させてから塩化ナト
リウム0から0.6Mによる直線グラジエント溶出を行い活
性画分を集める。更にゲル濾過クロマト処理(フアーマ
シア社製セフアデツクスG−100)により、活性画分を
集め、上記と同様に再びゲル濾過クロマト処理を行い精
製酵素液標品を得る。これは、電気泳動的に均一であ
る。なお、この酵素の結晶化品は得られていない。Sporoboromomyces salmonicolor IFO1038 grown in a medium (pH 5.0) consisting of 5% glucose and 5% corn stay liquor was collected by centrifugation,
After washing with a phosphate buffer, the cells are crushed with Dynomill (manufactured by Shinmaru Enterprise Co., Ltd.) to extract the enzyme. After centrifugation, the resulting cell-free extract was ammonium sulfate fractionated and
%, Collect the saturated fraction. After dialysis overnight, it is adsorbed on a DEAE-Sephacel (manufactured by Pharmacia) column, and then linear gradient elution with 0 to 0.6 M of sodium chloride is performed to collect the active fraction. Furthermore, the active fractions are collected by gel filtration chromatography (Sephadex G-100 manufactured by Pharmacia), and gel filtration chromatography is performed again in the same manner as above to obtain a purified enzyme liquid preparation. It is electrophoretically uniform. A crystallized product of this enzyme has not been obtained.
次に、本発明で使用する酵素の理化学的性質を記す。 Next, the physicochemical properties of the enzyme used in the present invention will be described.
作用:補酵素NADPHの存在下、1モルのアルデヒド
又はケトン類を基質とし、1モルのアルコール類を精製
する。Action: In the presence of coenzyme NADPH, 1 mol of aldehyde or ketone is used as a substrate to purify 1 mol of alcohol.
基質特異性:下記各基質に対する活性を、γ−クロ
ルアセト酢酸エチルを基準として表わす。尚、活性測定
法は次による。Substrate specificity: The activity for each of the following substrates is expressed based on ethyl γ-chloroacetoacetate. The activity measuring method is as follows.
基質600nモルとNADPH192nモルを0.6mlの酵素液(0.1M
リン酸緩衝液、pH7.0)に添加し、37℃、340nmの吸光度
変化を測定し求める。Substrate 600 nmol and NADPH 192 nmol in 0.6 ml of enzyme solution (0.1 M
Add to phosphate buffer, pH 7.0) and measure the change in absorbance at 340nm at 37 ℃ to obtain the value.
(i) ケトン類に対する活性 (ii) 補酵素 ・NADPHに対し活性有り。(I) Activity against ketones (Ii) Coenzyme ・ Active against NADPH.
・NADPH(ニコチンアミドアデニンジヌクレオチド)に
対し作用しない。・ Does not act on NADPH (nicotinamide adenine dinucleotide).
(iii) アルコール類 第2表のアルコール類に対して実質的に活性は認めら
れない。(Iii) Alcohols Substantially no activity is observed against the alcohols shown in Table 2.
至適pH及び安定pH範囲 至適pHは7近辺にある、また、pH6〜10で55℃、10分
間処理した場合でも80%以上の活性が残存する。 Optimum pH and stable pH range The optimum pH is around 7, and 80% or more of the activity remains even when treated at pH 6 to 10 at 55 ° C for 10 minutes.
至適温度及び安定温度範囲 至適温度は60℃付近にある。また、pH7.0、10分間処
理では40℃で100%、60℃で70%の活性が残存する。Optimal temperature and stable temperature range The optimal temperature is around 60 ° C. When treated at pH 7.0 for 10 minutes, 100% activity at 40 ° C and 70% activity at 60 ° C remain.
金属イオン及び各種薬剤の影響 光学選択性 γ−置換アセト酢酸エステルの還元反応生成物も
(R)−体で光学純度は97%ee以上である。Effects of metal ions and various drugs Optical Selectivity The reduction reaction product of γ-substituted acetoacetic acid ester is also the (R) -form, and the optical purity is 97% ee or more.
生成物の光学純度は、(+)−α−メトキシ−α−ト
リフルオロメチルフエニル酢酸(MTPA)とのエステルを
合成し、ジアステレオマー化合物とした後、高速液体ク
ロマトグラフイ(HPLC)により分離定量する。 The optical purity of the product was determined by high-performance liquid chromatography (HPLC) after synthesizing an ester with (+)-α-methoxy-α-trifluoromethylphenylacetic acid (MTPA) to obtain a diastereomeric compound. Separate and quantify.
HPLC条件 カラム:Partisil5(ワツトマン社製)(4.6φ×250mm) 移動相:ヘキサン:テトラクロロフラン:メタノール=
600:100:1 速度:2.0ml/分 検出(吸光度波長):217nm 有機溶媒に対する安定性 第5表の有機溶媒を含むpH7.0のリン酸緩衝液中で28
℃、24時間処理した場合でも80%以上の活性を保有して
いる。HPLC conditions Column: Partisil5 (manufactured by Wattman) (4.6φ x 250 mm) Mobile phase: Hexane: Tetrachlorofuran: Methanol =
600: 100: 1 Velocity: 2.0 ml / min Detection (Absorbance wavelength): 217 nm Stability against organic solvents 28 in pH 7.0 phosphate buffer containing organic solvents in Table 5
It retains 80% or more of activity even when it is treated at ℃ for 24 hours.
等電点 pH4.7 分子量 32,000(セフアデツクスG−100のゲル濾過法) 36,500〔SDS(ソジウムドデシルサルフエート)電気泳
動法〕 本発明で使用する新規還元酵素を生産するには、常法
に従つて、当該菌を培養することができる。培養に用い
られる培地は微生物の生育に必要な炭素源、窒素源、無
機物質等を含む通常の培地である。更に、ビタミン、ア
ミノ酸等の有機微量栄養素を添加すると望ましい結果が
得られる場合が多い。 Isoelectric point pH 4.7 Molecular weight 32,000 (Sephadex G-100 gel filtration method) 36,500 [SDS (sodium dodecyl sulphate) electrophoresis method] To produce the novel reductase used in the present invention, a conventional method is used. Then, the bacterium can be cultured. The medium used for culturing is an ordinary medium containing a carbon source, a nitrogen source, an inorganic substance and the like necessary for the growth of microorganisms. In addition, the addition of organic micronutrients such as vitamins and amino acids often produces desirable results.
培養は好気的条件下、pH3〜8、温度10〜40℃の任意
の範囲に制御しつつ1〜10日間行う。The culture is carried out under aerobic conditions for 1 to 10 days while controlling the pH to be in the range of 3 to 8 and the temperature to be in the range of 10 to 40 ° C.
当該菌を培養して電気泳動的に均一なアルデヒド還元
酵素を得るには、通常の硫安分画、アフイニテイクロマ
トグラフイ、イオン交換クロマトグラフイ、ゲルろ過ク
ロマトグラフイ等が用いられる。In order to obtain the electrophoretically uniform aldehyde reductase by culturing the bacterium, ordinary ammonium sulfate fractionation, affinity chromatography, ion exchange chromatography, gel filtration chromatography and the like are used.
γ−置換アセト酢酸エステルからの(R)−γ−置換
−β−ハイドロキシ酪酸エステルの合成にあたつて使用
する酵素の形態は、精製、半精製、酵素含有菌体、菌体
処理物及びこれらの固定化物などいづれも使用出来る。
使用菌株であるスポロボロマイセスサルモニカラーIFO1
038には(S)−γ−置換−β−ハイドロキシ酪酸エス
テルを生成する酵素も含有されているため予め除去して
おく必要がある。The form of the enzyme used in the synthesis of (R) -γ-substituted-β-hydroxybutyric acid ester from γ-substituted acetoacetic acid ester is as follows: purified, semi-purified, enzyme-containing cells, treated cells and Any of the immobilized products can be used.
The strain used, Sporoboromyces salmonicolor IFO1
Since 038 also contains an enzyme that produces (S) -γ-substituted-β-hydroxybutyric acid ester, it must be removed in advance.
基質としてのγ−置換アセト酢酸エステルの使用濃度
は20重量%程度迄可能であるが、濃度上昇につれ反応が
阻害される傾向にあるため、10重量%以下か又は低濃度
分添又は連続添加が望ましい。The concentration of γ-substituted acetoacetic acid ester used as a substrate can be up to about 20% by weight, but the reaction tends to be inhibited as the concentration increases, so 10% by weight or less or low concentration addition or continuous addition is possible. desirable.
γ−置換アセト酢酸エステルのγ位置換基としては、
クロル、ブロム、フルオロ、アジド基などが好ましく、
エステル基としては炭素数1〜10のアルキル基が好まし
い。As the γ-position substituent of γ-substituted acetoacetic acid ester,
Chlorine, bromine, fluoro, azido group and the like are preferable,
As the ester group, an alkyl group having 1 to 10 carbon atoms is preferable.
補酵素として、NADPHを必須とするため、反応系にNAD
PHを必要量予め添加するか、又はNADPHを生成するシス
テムを共存させる。このシステムには、例えば、グルコ
ースデヒドロゲナーゼによるグルコースからのグルコン
酸生成反応に於けるNADPのNADPHへの変換を利用するNAD
PH再生システム等を好適に利用出来る。Since NADPH is essential as a coenzyme, NAD is added to the reaction system.
The required amount of PH is added in advance, or a system for producing NADPH is allowed to coexist. This system includes, for example, NAD that utilizes the conversion of NADP to NADPH in the gluconic acid production reaction from glucose by glucose dehydrogenase.
It is possible to use a PH playback system, etc.
反応温度は5〜70℃、好ましくは20〜40℃、反応pHは
4〜10、好ましくは6〜8に調整すれば、本発明の目的
は十分に発揮される。If the reaction temperature is adjusted to 5 to 70 ° C., preferably 20 to 40 ° C., and the reaction pH is adjusted to 4 to 10, preferably 6 to 8, the object of the present invention is sufficiently exhibited.
以下、実施例で本発明を具体的に説明する。例中、特
に断わらない限り%は重量%である。Hereinafter, the present invention will be specifically described with reference to Examples. In the examples,% means% by weight unless otherwise specified.
酸素単離例 グルコース5重量%、コーンステイープリカー5重量
%から成るpH6.0の培地5mlを試験管に取り、スポロボロ
ミセス・サルモニカラーIFO1038を接種して28℃で2日
間振とう培養を行ない種培養を得た。Oxygen isolation example 5 ml of glucose 6.0 wt% and corn stay liquor 5 wt% of pH 6.0 was placed in a test tube, inoculated with Sporoboromyces salmonicolor IFO1038, and shake culture was performed at 28 ° C for 2 days. Seed culture was obtained.
上記と同一組成の培地500mlを2容フラスコに取
り、種培養5mlを添加して28℃で4日間振とう培養を行
なつた。次に上記フラスコ10本を合わせて、5の培養
液から遠心分離(2800G、20分間)で回収した培養菌体
を0.01Mリン酸緩衝液(pH7.4)で洗浄後、ダイノミル
(ビーズ0.25〜0.5mmφ)で20分間処理を行ない、28000
Gで20分間遠心分離してケン濁物質を除き、粗酵素液を
得た。このものに、硫安を加えて60〜80飽和%の画分を
遠心分離(28,000G×30分)で回収し、0.01M酸緩衝液
(pH7.0)で20時間透析した。次に、DEAE−セフアセル
カラムクロマトグラフイ(1.6φ×30cm)に吸着させ、
上記緩衝液で洗浄後、塩化ナトリウム0から0.6Mを含む
同緩衝液による直線グラジエント溶出を行なつた。活性
を示した画分を集め限外ろ過機(アミコン社、YM10)で
濃縮後、ゲルろ過カラム(セフアデツクス、G−100、
2.0φ×90cm)に供給し、0.1MのNaClを含む上記緩衝液
でクロマトグラフを行ない、活性を示した画分を集め、
上記と同様の方法でゲルろ過クロマトグラフイを行ない
精製酵素液を調製した。このものは電気泳動的に単一バ
ンドを示した。500 ml of the medium having the same composition as described above was placed in a 2-volume flask, 5 ml of the seed culture was added, and shaking culture was carried out at 28 ° C. for 4 days. Next, the above 10 flasks were combined, and the cultured bacterial cells recovered by centrifugation (2800 G, 20 minutes) from the culture solution of 5 were washed with 0.01 M phosphate buffer (pH 7.4), and then Dynomill (beads 0.25 ~ 0.5mmφ) for 20 minutes, 28000
The crude enzyme solution was obtained by centrifugation at G for 20 minutes to remove suspended matter. Ammonium sulphate was added to this, and the fraction of 60-80% saturation was collected by centrifugation (28,000 G x 30 minutes) and dialyzed against 0.01 M acid buffer (pH 7.0) for 20 hours. Next, it was adsorbed on DEAE-Sephacel column chromatography (1.6 φ × 30 cm),
After washing with the above buffer, linear gradient elution with the same buffer containing 0 to 0.6 M of sodium chloride was performed. Fractions showing activity were collected and concentrated by an ultrafiltration machine (Amicon, YM10), and then gel filtration column (Sephadex, G-100,
2.0 φ × 90 cm), and chromatograph with the above buffer containing 0.1 M NaCl to collect the fractions showing activity,
Gel filtration chromatography was performed in the same manner as above to prepare a purified enzyme solution. This product electrophoretically showed a single band.
実施例1 酵素単離例で得た精製酵素を使用し第6表の条件下、
還元反応を行なつた。反応終了液を酢酸エチル200mlで
2回抽出した後、Na2SO4で脱水後酢酸エチルを減圧除去
した。残つた無色透明の液体をNMR分析した結果、次の
とおりであつたのでγ−クロル−β−ハイドロキシ酪酸
エチルであることを確認した。Example 1 Using the purified enzyme obtained in the enzyme isolation example, under the conditions of Table 6,
A reduction reaction was performed. The reaction-terminated liquid was extracted twice with 200 ml of ethyl acetate, dehydrated with Na 2 SO 4 and the ethyl acetate was removed under reduced pressure. As a result of NMR analysis of the remaining colorless and transparent liquid, it was confirmed to be ethyl γ-chloro-β-hydroxybutyrate as shown below.
NMR(CDCl3)δ(ppm): 1.25(3H、tr、CH3 CH2−) 3.22(1H、br、−OH) またGC分析により純度98.2%で収量は0.474g(収率92
%)であつた。このものはMTPAエステルのHPLC分析より
光学純度97%eeの(R)−体であつた。NMR (CDCl 3 ) δ (ppm): 1.25 (3H, tr, CH 3 CH 2 −) 3.22 (1H, br, -OH) In addition, GC analysis showed a purity of 98.2% and a yield of 0.474 g (yield 92
%). This product was the (R) -form with an optical purity of 97% ee as determined by HPLC analysis of MTPA ester.
第6表中の酸素活性Uは次による。 The oxygen activity U in Table 6 is as follows.
γ−クロルアセト酢酸エチルエステルから1分間に1
μモルのγ−クロル−β−ハイドロキシ酪酸エチルエス
テルを生成する能力を1単位(U)とする。1 per minute from γ-chloroacetoacetic acid ethyl ester
The capacity to produce μmol of γ-chloro-β-hydroxybutyric acid ethyl ester is defined as 1 unit (U).
実施例2 第7表に示すNADPHの再生システムを含む条件下、第
8表のγ−置換アセト酢酸エステルを基質として反応を
開始し、0.5N−NaOHでpHを6.5に維持しつつ20時間反応
した。反応終了後実施例1と同様に操作し、生成物を分
析した。NMR分析結果、生成物を確認した。また、収量
(率)、光学純度等を第8表に示す。 Example 2 Under conditions including the NADPH regeneration system shown in Table 7, the reaction was started using the γ-substituted acetoacetic acid ester shown in Table 8 as a substrate, and the reaction was carried out for 20 hours while maintaining the pH at 6.5 with 0.5N-NaOH. did. After the completion of the reaction, the same operation as in Example 1 was conducted to analyze the product. As a result of NMR analysis, the product was confirmed. Table 8 shows yield (rate), optical purity and the like.
γ−クロル−β−ハイドロキシ酪酸メチル NMR(CDCl3)δ(ppm): 3.6(3H、s、CH3−) 3.22(1H、br、−OH) γ−クロル−β−ハイドロキシ酪酸エチル 実施例1に同じ。 γ-Chloro-β-methyl hydroxybutyrate NMR (CDCl 3 ) δ (ppm): 3.6 (3H, s, CH 3 −) 3.22 (1H, br, -OH) γ-Chloro-β-ethyl hydroxybutyrate Same as in Example 1.
γ−クロル−β−ハイドロキシ酪酸オクチル NMR(CDCl3)δ(ppm): 0.88(3H、tr、CH 3−(CH2)n−) 1.28(10、s、−(CH 2)5−) 3.22(1H、br、−OH) γ−ブロモ−β−ハイドロキシ酪酸エチル γ−フルオロ−β−ハイドロキシ酪酸エチル いずれもクロル体エチルエステルにほぼ同じ。γ-Chloro-β-octyl hydroxybutyrate NMR (CDCl 3 ) δ (ppm): 0.88 (3H, tr, CH 3- (CH 2 ) n- ) 1.28 (10, s,-( CH 2 ) 5- ) 3.22 (1H, br, -OH) γ-Bromo-β-hydroxybutyric acid ethyl γ-fluoro-β-hydroxybutyric acid ethyl All are almost the same as the chloro ethyl ester.
γ−アジド−β−ハイドロキシ酪酸エチル NMR(CDCl3)δ(ppm): 1.25(3H、tr、CH 3CH2−) 3.22(1H、br、−OH) 〔発明の効果〕 本発明では、嫌気培養の必要なく、また温度安定性の
よい還元酸素を用いて、高収率かつ光学純度にすぐれた
(R)−γ−置換−β−ハイドロキシ酪酸エステルを製
造でき、工業的意義は大きい。γ-Azido-β-ethyl hydroxybutyrate NMR (CDCl 3 ) δ (ppm): 1.25 (3H, tr, CH 3 CH 2 —) 3.22 (1H, br, -OH) EFFECTS OF THE INVENTION In the present invention, it is possible to obtain (R) -γ-substituted-β-hydroxybutyric acid ester excellent in high yield and optical purity by using reduced oxygen which does not require anaerobic culture and has good temperature stability. It can be manufactured and has great industrial significance.
───────────────────────────────────────────────────── フロントページの続き (72)発明者 橋本 正道 町田市旭町3丁目5番1号 電気化学工 業株式会社中央研究所内 審査官 谷口 博 ─────────────────────────────────────────────────── ─── Continued Front Page (72) Masamichi Hashimoto Inventor Masamichi Hashimoto 3-5-1, Asahimachi, Machida-shi Denki Kagaku Co., Ltd. Central Research Laboratory Examiner Hiroshi Taniguchi
Claims (1)
マイセス属由来の還元型ニコチンアミド・アデニン・ジ
ヌクレオチド・リン酸依存性還元酵素を作用させる事を
特徴とする(R)−γ−置換−β−ハイドロキシ酪酸エ
ステルの製造法1. A (R) -γ-substituted, characterized in that a reduced nicotinamide / adenine / dinucleotide / phosphate-dependent reductase derived from the genus Sporoboromyces is allowed to act on a γ-substituted acetoacetic acid ester. Process for producing -β-hydroxybutyric acid ester
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP62142916A JP2566960B2 (en) | 1987-06-08 | 1987-06-08 | Method for producing (R) -r-substituted-β-hydroxybutyric acid ester |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP62142916A JP2566960B2 (en) | 1987-06-08 | 1987-06-08 | Method for producing (R) -r-substituted-β-hydroxybutyric acid ester |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS63304991A JPS63304991A (en) | 1988-12-13 |
| JP2566960B2 true JP2566960B2 (en) | 1996-12-25 |
Family
ID=15326606
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP62142916A Expired - Fee Related JP2566960B2 (en) | 1987-06-08 | 1987-06-08 | Method for producing (R) -r-substituted-β-hydroxybutyric acid ester |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP2566960B2 (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005018579A2 (en) | 2003-08-11 | 2005-03-03 | Codexis, Inc. | Enzymatic processes for the production of 4-substituted 3-hydroxybutyric acid derivatives and vicinal cyano, hydroxy substituted carboxylic acid esters |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4012257B2 (en) | 1997-02-07 | 2007-11-21 | 株式会社カネカ | Novel carbonyl reductase, gene encoding the same, and method of using them |
-
1987
- 1987-06-08 JP JP62142916A patent/JP2566960B2/en not_active Expired - Fee Related
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005018579A2 (en) | 2003-08-11 | 2005-03-03 | Codexis, Inc. | Enzymatic processes for the production of 4-substituted 3-hydroxybutyric acid derivatives and vicinal cyano, hydroxy substituted carboxylic acid esters |
Also Published As
| Publication number | Publication date |
|---|---|
| JPS63304991A (en) | 1988-12-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP4394647B2 (en) | Method for producing optically active tetrahydrothiophene derivative and method for crystallizing optically active tetrahydrothiophene-3-ol | |
| CA2094191C (en) | Stereoselective microbial or enzymatic reduction of 3,5-dioxo esters to 3-hydroxy-5-oxo, 3-oxo-5-hydroxy, and 3,5-dihydroxy esters | |
| US5413921A (en) | Method of the production of (s)-gamma-halogenated-γ-hydroxybutyric acid esters | |
| JP2566960B2 (en) | Method for producing (R) -r-substituted-β-hydroxybutyric acid ester | |
| US6214610B1 (en) | Process for the preparation of optically active N-benzyl-3-pyrrolidinol | |
| US5811294A (en) | Production of optically active 1,2-dihydroxyindance derivatives by asymetric assimilation | |
| JP2696127B2 (en) | Method for producing optically active 2-hydroxycarboxylic acid | |
| JPH0473998B2 (en) | ||
| JP2538597B2 (en) | Novel ring enzyme | |
| KR20010041061A (en) | Process for producing (r)-2-hydroxy-1-phenoxypropane derivatives | |
| JPH04341195A (en) | Production of optically active mandelic acid | |
| JPH10502531A (en) | Chiral synthesis of 2-hydroxycarboxylic acid using dehydrogenase | |
| Giovannini et al. | Bacillus stearothermophilus alcohol dehydrogenase: A new catalyst to obtain enantiomerically pure bicyclic octen-and hepten-ols and-ones | |
| JPS5923794B2 (en) | Manufacturing method of dihydroxyacetone | |
| US5232853A (en) | Method for producing (2r,3s)-3-hydroxy-2-methylbutyrate by microbial reduction | |
| JP2981250B2 (en) | Method for producing D-pantothenonitrile | |
| JPH03285689A (en) | Production of optically active 3-hydroxyfatty ester derivative | |
| JP2750017B2 (en) | Novel enzyme, method for producing the same, and method for producing optically active (R) -2-hydroxy-4-phenylbutyric acid | |
| JPS63188393A (en) | Production of optically active 2-hydroxybutyric acid derivative | |
| JP2946055B2 (en) | Method for producing optically active (S)-(+)-3-halo-1,2-propanediol | |
| JP3893721B2 (en) | Method for producing optically active compound | |
| JP4270910B2 (en) | Process for producing optically active 2-hydroxy-2-trifluoroacetic acids | |
| JPH0147159B2 (en) | ||
| JPH02295970A (en) | Preparation of optically active propane-2-ol derivative | |
| JP3088205B2 (en) | Method for producing optically active 1,3-butanediol |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| S531 | Written request for registration of change of domicile |
Free format text: JAPANESE INTERMEDIATE CODE: R313531 |
|
| R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
| LAPS | Cancellation because of no payment of annual fees |